Performance of Hair  Testing for Cocaine Use-Comparison of Five Laboratories Using Blind Reference Specimens. 2023

E Dale Hart, and Svante Vikingsson, and Ruth E Winecker, and Amy L Evans, and Edward J Cone, and John M Mitchell, and Eugene D Hayes, and Ronald R Flegel
Center for Forensic Science, RTI International, 3040 East Cornwallis Rd., Research Triangle Park, NC 27709, USA.

The purpose of this study was to compare results from five commercial hair testing laboratories conducting workplace drug testing with regard to bias, precision, selectivity and decontamination efficiency. Nine blind hair specimens, including cocaine-positive drug user specimens (some contaminated with methamphetamine) and negative specimens contaminated with cocaine, were submitted in up to five replicates to five different laboratories. All laboratories correctly identified cocaine in all specimens from drug users. For an undamaged hair specimen from a cocaine user, within-laboratory Coefficients of Variation (CVs) of 5-22% (median 8%) were reported, showing that it is possible to produce a homogenous proficiency testing sample from drug user hair. Larger CVs were reported for specimens composed of blended hair (up to 29%) and curly/damaged hair (19-67%). Quantitative results appeared to be method-dependent, and the reported cocaine concentrations varied up to 5-fold between the laboratories, making interlaboratory comparisons difficult. All laboratories reported at least one positive result in specimens contaminated with cocaine powder, followed by sweat and shampoo treatments. Benzoylecgonine, norcocaine, cocaethylene and hydroxylated cocaine metabolites were all detected in cocaine powder-contaminated specimens. This indicates that current industry standards for analyzing and reporting positive cocaine results are not completely effective at identifying external contamination. Metabolite ratios between meta- or para-hydroxy-cocaine and cocaine were 6- and 10-fold lower in contaminated specimens compared to those observed in cocaine user specimens, supporting their potential use in distinguishing samples positive due to contamination and drug use.

UI MeSH Term Description Entries
D007753 Laboratories Facilities equipped to carry out investigative procedures. Laboratory
D011208 Powders Substances made up of an aggregation of small particles, as that obtained by grinding or trituration of a solid drug. In pharmacy it is a form in which substances are administered. (From Dorland, 28th ed) Powder
D003042 Cocaine An alkaloid ester extracted from the leaves of plants including coca. It is a local anesthetic and vasoconstrictor and is clinically used for that purpose, particularly in the eye, ear, nose, and throat. It also has powerful central nervous system effects similar to the amphetamines and is a drug of abuse. Cocaine, like amphetamines, acts by multiple mechanisms on brain catecholaminergic neurons; the mechanism of its reinforcing effects is thought to involve inhibition of dopamine uptake. Cocaine HCl,Cocaine Hydrochloride,HCl, Cocaine,Hydrochloride, Cocaine
D006197 Hair A filament-like structure consisting of a shaft which projects to the surface of the SKIN from a root which is softer than the shaft and lodges in the cavity of a HAIR FOLLICLE. It is found on most surfaces of the body. Fetal Hair,Hair, Fetal,Lanugo,Fetal Hairs,Hairs,Hairs, Fetal
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D019970 Cocaine-Related Disorders Disorders related or resulting from use of cocaine. Cocaine Abuse,Cocaine Addiction,Cocaine Dependence,Abuse, Cocaine,Addiction, Cocaine,Cocaine Related Disorders,Cocaine-Related Disorder,Dependence, Cocaine,Dependences, Cocaine,Disorder, Cocaine-Related,Disorders, Cocaine-Related

Related Publications

E Dale Hart, and Svante Vikingsson, and Ruth E Winecker, and Amy L Evans, and Edward J Cone, and John M Mitchell, and Eugene D Hayes, and Ronald R Flegel
February 2012, Forensic science international,
E Dale Hart, and Svante Vikingsson, and Ruth E Winecker, and Amy L Evans, and Edward J Cone, and John M Mitchell, and Eugene D Hayes, and Ronald R Flegel
August 2013, Journal of applied toxicology : JAT,
E Dale Hart, and Svante Vikingsson, and Ruth E Winecker, and Amy L Evans, and Edward J Cone, and John M Mitchell, and Eugene D Hayes, and Ronald R Flegel
May 1999, Journal of forensic sciences,
E Dale Hart, and Svante Vikingsson, and Ruth E Winecker, and Amy L Evans, and Edward J Cone, and John M Mitchell, and Eugene D Hayes, and Ronald R Flegel
May 2004, Addiction (Abingdon, England),
E Dale Hart, and Svante Vikingsson, and Ruth E Winecker, and Amy L Evans, and Edward J Cone, and John M Mitchell, and Eugene D Hayes, and Ronald R Flegel
January 1972, Annals of clinical laboratory science,
E Dale Hart, and Svante Vikingsson, and Ruth E Winecker, and Amy L Evans, and Edward J Cone, and John M Mitchell, and Eugene D Hayes, and Ronald R Flegel
January 2023, Frontiers in public health,
E Dale Hart, and Svante Vikingsson, and Ruth E Winecker, and Amy L Evans, and Edward J Cone, and John M Mitchell, and Eugene D Hayes, and Ronald R Flegel
October 2006, Journal of analytical toxicology,
E Dale Hart, and Svante Vikingsson, and Ruth E Winecker, and Amy L Evans, and Edward J Cone, and John M Mitchell, and Eugene D Hayes, and Ronald R Flegel
May 2015, Archives of pathology & laboratory medicine,
E Dale Hart, and Svante Vikingsson, and Ruth E Winecker, and Amy L Evans, and Edward J Cone, and John M Mitchell, and Eugene D Hayes, and Ronald R Flegel
October 1998, Therapeutic drug monitoring,
E Dale Hart, and Svante Vikingsson, and Ruth E Winecker, and Amy L Evans, and Edward J Cone, and John M Mitchell, and Eugene D Hayes, and Ronald R Flegel
August 1976, American journal of hospital pharmacy,
Copied contents to your clipboard!